Novel Cell Sources in Cell Therapy: Overcoming Scalability and Safety Limits | Advanced Therapies Week 2026
Dr. Abdulkader Rahmo, PhD, President of SMSbiotech, delivered a keynote presentation at Advanced Therapies Week in San Diego titled “Exploring Novel Cell Sources to Overcome Limitations in Current Modalities.” In this session, Dr. Rahmo examines the structural challenges facing today’s cell therapy and gene therapy platforms — including scalability constraints, manufacturing variability, regulatory complexity, safety considerations, and cost of goods. As demand accelerates across regenerative medicine and advanced biologics, identifying stable, reproducible, and clinically viable cell sources has become essential for long-term industry growth.
This presentation provides insight into how next-generation adult cell platforms may help overcome limitations associated with traditional stem cell approaches, while supporting GMP scalability, genomic stability, and regulatory alignment. For professionals in biotechnology, pharmaceutical development, cell and gene therapy, and advanced therapy medicinal products (ATMPs), this keynote offers strategic perspective on the future of scalable regenerative medicine and advanced therapeutics innovation.
